It is interesting to note that CCAT1 and cMYC that show significantly higher expression levels in colorectal low-grade adenomas, advanced adenomas, and adenocarcinomas, do not provide a significant prognosis prediction impact (Figs. 1 and 2). The gene discussed is MYC; the disease is adenoma.